AIM: Exclusion diets have been shown to prolong remission in Crohn's disease (CD). We assessed IgG4-targeted exclusion diets in patients with CD. METHOD: Forty patients with symptomatic CD were recruited. Their sera were tested for IgG4 antibodies to 14 specific food antigens and each subject's four most reactive foods were excluded for 4 weeks. Disease activity was assessed using a modified CD activity index (mCDAI). Questionnaire and inflammatory markers were measured before and on completion of the exclusion diet. RESULTS: Eleven patients did not complete the study, leaving 29 for analysis. Of these, 26 (90%) reported symptomatic improvement with a reduction in mCDAI from a mean of 171-97.5 (P = 0.0001). The ESR fell from 23 to 17 mm/h (P = 0.021) and the IgG4 titres for the excluded foods fell from a mean of 3015-2306 mcgA/l (P = 0.003). CONCLUSION: IgG4-guided exclusion diets resulted in significant symptomatic improvement with an objective fall in an inflammatory marker. This approach may be useful in clinical practice.
AIM: Exclusion diets have been shown to prolong remission in Crohn's disease (CD). We assessed IgG4-targeted exclusion diets in patients with CD. METHOD: Forty patients with symptomatic CD were recruited. Their sera were tested for IgG4 antibodies to 14 specific food antigens and each subject's four most reactive foods were excluded for 4 weeks. Disease activity was assessed using a modified CD activity index (mCDAI). Questionnaire and inflammatory markers were measured before and on completion of the exclusion diet. RESULTS: Eleven patients did not complete the study, leaving 29 for analysis. Of these, 26 (90%) reported symptomatic improvement with a reduction in mCDAI from a mean of 171-97.5 (P = 0.0001). The ESR fell from 23 to 17 mm/h (P = 0.021) and the IgG4 titres for the excluded foods fell from a mean of 3015-2306 mcgA/l (P = 0.003). CONCLUSION: IgG4-guided exclusion diets resulted in significant symptomatic improvement with an objective fall in an inflammatory marker. This approach may be useful in clinical practice.
Authors: James D Lewis; Lindsey Albenberg; Dale Lee; Mario Kratz; Klaus Gottlieb; Walter Reinisch Journal: Inflamm Bowel Dis Date: 2017-02 Impact factor: 5.325
Authors: Dale Lee; Lindsey Albenberg; Charlene Compher; Robert Baldassano; David Piccoli; James D Lewis; Gary D Wu Journal: Gastroenterology Date: 2015-01-15 Impact factor: 22.682
Authors: Lindsey Albenberg; Colleen M Brensinger; Qufei Wu; Erin Gilroy; Michael D Kappelman; Robert S Sandler; James D Lewis Journal: Gastroenterology Date: 2019-03-11 Impact factor: 22.682
Authors: Aaron B Cohen; Dale Lee; Millie D Long; Michael D Kappelman; Christopher F Martin; Robert S Sandler; James D Lewis Journal: Dig Dis Sci Date: 2012-08-26 Impact factor: 3.199
Authors: Berkeley N Limketkai; Zipporah Iheozor-Ejiofor; Teuta Gjuladin-Hellon; Alyssa Parian; Laura E Matarese; Kelly Bracewell; John K MacDonald; Morris Gordon; Gerard E Mullin Journal: Cochrane Database Syst Rev Date: 2019-02-08